A neuroimmunological model of antisocial and borderline personality disorders

Human Psychopharmacology

Volumn 12, Issue 4, 1997, Pages 291-308

  Holden, Robyn J ^a   Pakula, Irwin S ^b   Mooney, Phyllis A ^c  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b South Eastern Sydney and Illawarra Area Health Service   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Antisocial personality disorder; Borderline personality disorder; Immunological change; Neuropeptides

Indexed keywords

BETA ENDORPHIN; GAMMA INTERFERON; INSULIN; NEUROPEPTIDE; NEUROPEPTIDE Y;

ANTISOCIAL BEHAVIOR; AUTOMUTILATION; BORDERLINE STATE; CLINICAL FEATURE; GENDER; HUMAN; NEUROIMMUNOLOGY; NEUROTRANSMISSION; PATHOLOGY; PERSONALITY DISORDER; PRIORITY JOURNAL; REVIEW;

EID: 0030849293     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199707/08)12:4<291::AID-HUP878>3.0.CO;2-H     Document Type: Review

References (147)

1. Adams, M. L. and Cicero, T. J. (1991). Effects of alcohol on beta-endorphin and reproductive hormones in the male rat. Alcohol: Clinical and Experimental Research, 15, 685-692.
2. Akabayashi, A., Wahlestedt, C., Alexander, J. T. and Leibowitz, S. F. (1994). Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion. Brain Research: Molecular Brain Research, 21, 55-61.
3. Alm, P. O, Alm, M., Humble, K., Leppert, J., Sorensen, S., Lidberg, L. and Oreland, L. (1994). Criminality and platelet monoamine oxidase activity in former juvenile delinquents as adults. Acta Psychiatrica Scandinavica, 89, 41-45.
4. Atienza, G., Andres, M. D., Rebolledo, E. and Aldegunde, M. (1992). Brain tryptophan uptake and sodium-potassium ATPase activity in long-term streptozotocin diabetic rats. Neurochemical Research, 17, 289-292.
5. Azam, M., Gupta, G. and Baquer, N. Z. (1990). Modulation of insulin receptors and catecholamines in rat brain in hypoglycaemia and hyperinsulinemia. Biochemistry International, 22, 1-9.
6. Ballenger, J. C., Goodwin, F. K., Major, L. F. and Brown, G. L. (1979). Alcohol and central serotonin metabolism in man. Archives of General Psychiatry, 36, 224-227.
7. Baskin, D. G., Woods, S. C., West, D. B., van Houten, M., Posner, B. I., Dorsa, D. M. and Porte, D. Jr. (1983). Immunocytochemical detection of insulin in rat hypothalamus and its possible uptake from cerebrospinal fluid. Endocrinology, 113, 1818-1825.
8. Beal, M. F., Walker, L. C., Storey, E., Segar, L., Price, D. L. and Cork, L. C. (1991). Neurotransmitters in neocortex of aged rhesus monkeys. Neurobiology and Aging, 12, 407-412.
9. Belfrage, H., Lidberg, L. and Oreland, L. (1992). Platelet monoamine oxidase activity in mentally disordered violent offenders. Acta Psychiatrica Scandinavica, 85, 218-221.
10. Benarroch, E. E. (1994). Neuropeptides in the sympathetic system: presence, plasticity, modulation, and implications. Annals of Neurology, 36, 6-13.
11. Bhattacharya, S. K. and Saraswati, M. (1991). Effect of intracerebroventricularly administered insulin on brain monoamines and acetylcholine in euglycaemic and alloxan-induced hypoglycaemic rats. Indian Journal of Experimental Biology, 29, 1095-1100.
12. Blackburn, R. and Lee-Evans, J. M. (1985). Reactions of primary and secondary psychopaths to anger-evoking situations. British Journal of Clinical Psychiatry, 24, 93-100.
13. Bonavera, J. J., Sahu, A., Kalra, S. P. and Kalra, P. S. (1994). The hypothalamic peptides, beta-endorphin, neuropeptide K and interleukin-1 beta, and the opiate morphine, enhance the excitatory amino acid-induced LH release under the influence of gonadal steroids. Journal of Neuroendocrinology, 6, 557-564.
14. Burgering, B. M. Th., Medema, R. H., Maassen, J. A., van de Wetering, M. L., van der Eb, A. J., McCormick, F. and Bos, J. L. ((1991). Insulin stimulation of gene expression mediated by p21ras activation. EMBO Journal, 10, 1103-1109.
15. Calabrese, V. P., Gruemer, H. D., Tripathi, H. L., Dewey, W., Fortner, C. A. and DeLorenzo, R. J. (1993). Serum Cortisol and cerebrospinal fluid beta-endorphins in status epilepticus. Their possible relation to prognosis. Archives of Neurology, 50, 689-693.
16. Carr, D. J. (1991). The role of endogenous opioids and their receptors in the immune system. Proceedings of the Society for Experimental Biology and Medicine, 198, 710-720.
17. Cintra, A., Fuxe, K. Solfrini, V., Agnati, L. F., Tinner, B., Wikstrom, A. C., Staines, W., Okret, S. and Gustafsson, J. A. (1991). Central peptidergic neurons as targets for glucocorticoid action. Evidence for the presence of glucocorticoid receptor immunoreactivity in various types of classes of peptidergic neurons. Journal of Steroid Biochemistry and Molecular Biology, 40, 93-103.
18. Clarke, D. W., Boyd, F. T., Kappy, M. S. and Raizada, M. K. (1984). Insulin binds to specific receptors and stimulates 2-deoxy-D-glucose uptake in cultured glial cells from rat brain. Journal of Biological Chemistry, 259, 11672-11675.
19. Clarke, D. W., Mudd, L. H., Boyd, F. T., Fields, M. and Raizada, M. K. (1986). Insulin is released from rat brain neuronal cells in culture. Journal of Neurochemistry, 47, 831-836.
20. Cleckley, H. (1988). The Mask of Sanity, 4th edn. C. V. Mosby, St. Louis.
21. Coccara, E. F. (1992). Impulsive aggression and central serotonergic system function in humans: an example of a dimensional brain-behaviour relationship. International Clinical Psychopharmacology, 7, 3-12.
22. Coccaro, E. F. and Kavoussi, R. J. (1991). Biological and pharmacological aspects of borderline personality disorder. Hospital Community Psychiatry, 42, 1029-1033.
23. Coccaro, E. F., Klar, H. and Siever, L. J. (1994). Reduced prolactin response to fenfluramine challenge in personality disorder patients is not due to deficiency of pituitary lactotrophs. Biological Psychiatry, 36, 344-346.
24. Coid, J. W. (1993). An affective syndrome in psychopaths with borderline personality disorder? British Journal of Psychiatry, 162, 641-650.
25. Coleman, J. W., Buckley, M. G., Holliday, M. R. and Morris, A. G. (1991). Interferon-gamma inhibits serotonin release from mouse peritoneal mast cells. European Journal of Immunology, 21, 2559-2564.
26. Craft, S., Dagogo-Jack, S. E., Wiethop, B. V., Murphy, C., Nevins, R. T., Fleischman, S., Rice, V., Newcomer, J. W. and Cryer, P. E. (1993). Effects of hypoglycaemia on memory and hormone levels in dementia of the Alzheimer type: a longitudinal study. Behavioural Neuroscience, 107, 926-940.
27. Dalayeun, J. F., Nores, J. M. and Bergal, S. (1993). Physiology of beta-endorphins. A close-up view and a review of the literature. Biomedical Pharmacotherapy, 47, 311-320.
28. Darko, D. F., Risch, S. C., Gillin, J. C. and Golshan, S. (1992). Association of beta-endorphin with specific clinical symptoms of depression. American Journal of Psychiatry, 149, 1162-1167.
29. de la Fuente, J. M., Lotstra, F., Goldman, S., Biver, F., Luxen, A., Bidaut, L., Stanus, E. and Mendlewicz, J. (1994). Temporal glucose metabolism in borderline personality disorder. Psychiatry Research, 55, 237-245.
30. Demitrack, M. A., Putnam, F. W., Rubinow, D. R., Pigott, T. A., Altemus, M., Krahn, D. D. and Gold, P. W. (1993). Relation of dissociative phenomena to levels of cerebrospinal fluid monoamine metabolies and beta-endorphin in patients with eating disorders: a pilot study. Psychiatry Research, 49, 1-10.
31. Desjardins, G. C., Brawer, J. R. and Beaudet, A. (1993). Estradiol is selectively neurotoxic to hypothalamic beta-endorphin neurons. Endocrinology, 132, 86-93.
32. Devinsky, O., Emoto, S., Nadi, N. S. and Theodore, W. H. (1993). Cerebrospinal fluid levels of neuropeptides, cortisol, and amino acids in patients with epilepsy. Epilepsia, 34, 255-261.
33. Eizirik, D. L., Sandler, S., Welsh, N., Cetkovic-Cvrlje, M., Nieman, A., Geller, D. A., Pipeleers, D. G., Bendtzen, K. and Hellerstrom, C. (1994). Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. Journal of Clinical Investigation, 93, 1968-1974.
34. Else, L. T., Wonderlich, S. A., Beatty, W. W., Christie, D. W. and Staton, R. D. (1993). Personlity characteristics of men who physically abuse women. Hospital Community Psychiatry, 44, 54-58.
35. Engelberg, H. (1992). Low serum cholesterol and suicide. Lancet, 339, 727-729.
36. Ernst, M., Devi, L., Silva, R. R., Gonzalez, N. M., Small, A. M., Malone, R. P. and Campbell, M. (1993). Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children. Psychopharmacology Bulletin, 29, 221-227.
37. Extein, I. L. and Gold, M. S. (1993). Hypothesized neurochemical models for psychiatric syndromes in alcohol and drug dependence. Journal of Addictive Diseases, 12, 29-43.
38. Fagan, T. J. and Lira, F. T. (1980). The primary and secondary sociopathic personality: Differences in frequency and severity of antisocial behaviors. Journal of Abnormal Psychology, 89, 493-496.
39. Farabollini, F., Albonetti, M. E., Aloisi, A. M., Facchinetti, F., Grasso, G., Lodi, L., Lupo, C. and Muscettola, M. (1993). Immune and neuroendocrine response to restraint in male and female rats. Psychoneuroendocrinology, 18, 375-182.
40. Favazza, A. R. and Rosenthal, R. J. (1993). Diagnostic issues in self-mutilation. Hospital and Community Psychiatry, 44, 134-140.
41. Ferin, M., Van Vugt, D. and Wardlaw, S. (1984a). The hypothalamic control of the menstrual cycle and the role of endogenous opioid peptides. Recent Progress in Hormone Research, 40, 441-485.
42. Ferin, M., Van Vugt, D. and Wardlaw, S. (1984b). The hypothalamic control of the menstrual cycle and the role of the endogenous opioid peptides, Recent Progress in Hormone Research, 40, 441-485.
43. Fishbein, D. H., Dax, E., Lozovsky, D. B. and Jaffe, J. H. (1992). Neuroendocrine responses to a glucose challenge in substance users with high and low levels of aggression, impulsivity, and antisocial personality. Neuropsychobiology, 25, 106-114.
44. Flood, J. F., Garland, J. S. and Morley, J. E. (1992). Evidence that cholecystokinin-enhanced retention is mediated by changes in opioid activity in the amygdala. Brain Research, 585, 94-104.
45. Freedman, D. S., Byers, T., Barrett, D. H., Stroup, N. E., Eaker, E. and Monroe-Blum, H. (1995). Plasma lipid levels and psychologic characteristics in men. American Journal of Epidemiology, 141, 507-517.
46. Garmey, J. C., Day, R. N., Day, K. H. and Veldhuis, J. D. (1993). Mechanisms of regulation of ovarian sterol metabolism by insulin-like growth factor type II: in vitro studies with swine granulosa. Endocrinology, 133, 800-808.
47. Ghaziuddin, M., Tsai, L., Naylor, M. and Ghaziuddin, N. (1992). Mood disorder in a group of self-cutting adolescents. Acta Paedopsychiatrica, 55, 103-105.
48. Golden, N. H. and Shenker, I. R. (1994). Amenorrhea in anorexia nervosa. Neuroendocrine control of hypothalamic dysfunction. International Journal of Eating Disorders, 16, 53-60.
49. Golomb, M., Fava, M., Abraham, M. and Rosenbaum, J. F. (1995). Gender differences in personality. American Journal of Psychiatry, 152, 579-582.
50. Goodnick, P. J., Henry, J. H. and Buki, V. M. V. (1995). Treatment of depression in patients with diabetes mellitus. Journal of Clinical Psychiatry, 56, 128-136.
51. Goodwin, G. M., Austin, M. P., Curran, S. M., Ross, M., Murray, C., Prentice, N., Ebmeier, K. P., Bennie, J., Carroll, S., Dick, H. and Fink, G. (1993). The elevation of plasma beta-endorphin levels in major depression. Journal of Affective Disorders, 29, 281-289.
52. Goyer, P. F., Andreason, P. J., Semple, W. E., Clayton, A. H., King, A. C., Compton-Toth, B. A., Schulz, S. C. and Cohen, R. M. (1994). Positron-emission tomography and personality disorders. Neuropsychopharmacology, 10, 21-28.
53. Gunderson, J. G. (1988). Personality disorders. In: The New Harvard Guide to Psychiatry, Nicoli Jr., A. M. (Ed.), Harvard University Press, Cambridge, MA, pp. 337-357.
54. Hansson, G. K. (1994). Immunological control mechanisms in plaque formation. Basic Research in Cardiology, 89(Suppl 1), 41-46.
55. Hawton, K., Cowen, P., Owens, D., Bond, A. and Elliot, M. (1993). Low serum cholesterol and suicide. British Journal of Psychiatry, 162, 818-825.
56. Hayashi, N. (1992). Neurotic symptoms of borderline patients: a case review study. Seishin Shinkeigaku Zasski, (Psychiatria Et Neurologia Japonica 94, 648-681.
57. Heijnen, C. J., Kavelaars, A. and Ballieux, R. E. (1991). Beta-endorphin: cytokine and neuropeptide. Immunology Reviews, 119, 41-63.
58. Heilig, M., McLeod, S., Koob, G. K. and Britton, K. T. (1992). Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test. Regulatory Peptides, 41, 61-69.
59. Heyes, M. P., Papagapiou, M., Leonard, C., Markey, S. P. and Auer, R. N. (1990). Brain and plasma quinolinic acid in profound insulin-induced hypoglycaemia. Journal of Neurochemistry, 54, 1027-1033.
60. Heyes, M. P., Saito, K. and Markey, S. P. (1992). Human macrophages convert L-tryptophan into ncurotoxin quinolinic acid. Biochemical Journal, 283, 633-635.
61. Hillbrand, M., Krystal, J. H., Sharpe, K. S. and Foster, H. G. (1994). Clinical predictors of self-mutilation in hospitalized forensic patients. Journal of Nervous and Mental Diseases, 182, 9-13.
62. Holden, R. J. and Mooney, P. A. (1994). Schizophrenia is a diabetic brain state: an elucidation of impaired neurometabolism. Medical Hypotheses, 43, 420-435.
63. Hollander, E., Stein, D. J., DeCaria, C. M., Cohen, L., Saoud, J. B., Skodol, A. E., Kellman, D., Rosnick, L. and Oldham, J. M. (1994). Serotonergic sensitivity in borderline personality disorder.: preliminary findings. American Journal of Psychiatry, 151, 277-280.
64. Holliday, J. and Gruol, D. L. (1993). Cytokine stimulation increases intracellular calcium and alters the response to quisqualate m cultured cortical astrocytes. Brain Research, 621, 233-241.
65. Holliday, M. R., Banks, E. M. S., Dearman, R. J., Kimber, I. and Coleman, J. W. (1994). Interactions of IFN-γ with IL-3 and IL-4 in the regulation of serotonin and arachidonate release from mouse peritoneal mast cells. Immunology, 82, 70-74.
66. Jhala, U. and Baly, D. L. (1994). Effect of chronic IL-1 beta infusion on glucose homeostasis and pancreatic insulin secretion. Life Sciences, 54, 413-422.
67. Kalra, S. P., Sahu, A. and Kalra, P. S. (1993). Ageing of the neuropeptidergic signals in rats. Journal of Reproduction and Fertility, 46(Suppl.), 11-19.
68. Kaplan, J. R., Manuck, S. B. and Shively, C. (1991). The effects of fat and cholesterol on social behaviour in monkeys. Psychosomatic Medicine, 53, 634-642.
69. Karpman, B. (1961). The structure of neuroses: With special differentials between neurosis, psychosis, homosexuality, alcoholism, psychopathy and criminality. Archives of Criminal Psychodynamics, 4, 599-646.
70. Kaye, W. H. and Weltzin, T. F. (1991). Neurochemistry of bulimia nervosa. Journal of Clinical Psychiatry, 52, 21-28.
71. Klip, A. and Marette, A. (1992). Acute and chronic signals controlling glucose transport in skeletal muscle. Journal of Cell Biology, 48, 51-60.
72. Kosten, T. R., Morgan, C. and Kreek, M. J. (1992). Beta endorphin levels during heroin, methadone, buprenorphine, and naloxone challenges: preliminary findings. Biological Psychiatry, 32, 523-528.
73. Kowalski, C., Michaeu, J., Corder, R., Gaillard, R. and Conte-Devolx, B. (1992). Age-related changes in cortico-releasing factor, somatostatin, neuropeptide Y, methionine enkephalin and beta-endorphin in specific rat brain areas. Brain Research, 582, 38-46.
74. Kozma, L., Baltensperger, K., Klarlund, J., Porras, A., Santos, E. and Czech, M. P. (1993). The Ras signaling pathway mimics insulin action on glucose transporter translocation. Proceedings of the National Academy of Sciences, USA, 90, 4460-4464.
75. Lackovic, Z. and Salkovic, M. (1990). Streptozotocin and alloxan produce alterations in rat brain monoamines independently of pancreatic beta cells destruction. Life Sciences, 46, 49-54.
76. Lieberman, J. A. and Koreen, A. R. (1993). Neurochemistry and neuroendocrinology of schizophrenia: a selective review. Schizophrenia Bulletin, 19, 371-429.
77. Linnoila, M. and Virkkunen, M. (1992a). Aggression, suicidality, and serotonin. Journal of Clinical Psychiatry, 53, 46-51.
78. Linnoila, M. and Virkkunen, M. (1992b). Biologic correlates of suicidal risk and aggressive behavioural traits. Journal of Clinical Psychopharmacology, 12, 19S-20S.
79. Linnoila, M., Virkkunen, M., Scheinin, M., Nuutila, A., Rimon, R. and Goodwin, F. K. (1983). Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behaviour. Life Sciences, 33, 2609-2614.
80. Lydiard, R. B. (1994). Neuropeptides and anxiety: focus on cholescystokinin. Clinical Chemistry, 40, 315-318.
81. Macs, M., Scharpe, S., Meltzer, H. Y., Okayli, G., Bosnians, E., D'Hondt, P., Vanden-Bossche, B. V. and Cosyns, P. (1994). Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response. Psychiatry Research, 54, 143-160.
82. Marks, J. L., Waite, K. and Li, M. (1993). Effects of streptozotocin-induced diabetes mellitus and insulin treatment on neuropeptide Y mRNA in the rat hypothalamus. Diabetologia, 36, 497-502.
83. Marlowe, M. J. (1993). Biological aspects of personality disorder. British Journal of Hospital Medicine, 49, 564-569.
84. Martin, D. M., Carlson, R. O. and Feldman, E. L. (1993). Interferon-γ inhibits DNA synthesis and insulin-like growth factor-II expression in human neuroblastoma cells. Journal of Neuroscience Research, 34, 489-501.
85. Mataga, N., Imamura, K. and Watanabe, Y. (1991). 6R-tetrahydrobiopterin perfusion enhances dopamine, serotonin, and glutamate outputs in dialysate from rat striatum and frontal cortex. Brain Research, 551, 64-71.
86. Mattson, M. P. and Cheng, B. (1993). Growth factors protect neurons against excitotoxic/ischemic damage by stabilizing calcium homeostasis. Stroke, 24, 1136-1145.
87. McCarthy, H. D., Dryden, S. and Williams, G. (1995). Interleukin-1 beta-induced anorexia and pyrexia in rat: relationship to hypothalamic neuropeptide Y. American Journal of Physiology, 269, E852-E857.
88. McKibbin, P. E., McCarthy, H. D., Shaw, P. and Williams, G. (1992). Insulin deficiency is a specific stimulus to hypothalamic neuropeptide Y: a comparison of the effects of insulin replacement and food restriction in streptozocin-diabetic rats. Peptides, 13, 721-727.
89. Mehta, V. K., Hao, W., Brooks-Worrell, B. M. and Palmer, J. P. (1994). Low-dose interleukin 1 and tumor necrosis factor individually stimulate insulin release but in combination cause suppression. European Journal of Endorcinology, 130, 208-214.
90. Meyers, C. A., Berman, S. A., Scheibel, R. S. and Hayman, A. (1992). Case report: acquired antisocial personality disorder associated with unilateral left orbital frontal lobe damage. Journal of Psychiatry and Neuroscience, 17, 121-125.
91. Miluscheva, E., Doda, M., Pasztor, E., Lajtha, A., Sershen, H. and Vizi, E. S. (1992). Regulatory interactions among axon terminals affecting the release of different transmitters from rat striatal slices under hypoxic and hypoglycaemic conditions. Journal of Neurochemistry, 59, 946-952.
92. Mohankumar, P. S., Thyagarajan, S. and Quadri, S. K. (1993). Interleukin-1β increases 5-hydroxyindoleacetic acid release in the hypothalamus in vivo. Brain Research Bulletin, 31, 745-748.
93. Moore, M. R. and Black, P. M. (1991). Neuropeptides. Neurosurgery Reviews, 14, 97-110.
94. Naidenova, N. N., Mishenev, M. V., Semke, V. I. A., Golovin, O. D. and Vasil'eva, O. A. (The characteristics of the interferon system parameters in typologically different groups of patients with borderline mental disorders during treatment). Zhurnal Nevropatologii I Psikhiatrii Imeni S. S. Korsakova, 94, 74-76.
95. Newman, J. P., Widom, C. S. and Nathan, S. (1985). Passive avoidance in syndromes of disinhibition: Psychopathy and extraversion. Journal of Personality and Social Psychology, 48, 1316-1327.
96. Ohue, T., Koshimura, K., Lee, K., Watanabe, Y. and Miwa, S. (1991). A novel action of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin, a cofactor for hydrolases of phenalalanine, tyrosine and tryptophan: enhancement of acetylcholine release in vivo in the rat hippocampus. Neuroscience Letters, 128, 93-96.
97. O'Keane, V., Moloney, E., O'Neill, H., O'Connor, A., Smith, C. and Dinan, T. G. (1992). Blunted prolactin responses to d-fenfluaramine in sociopathy. Evidence for subsensitivity of central serotonergic function. British Journal of Psychiatry, 160, 643-646.
98. Paris, J. (1994). The etiology of borderline personality disorder: a biopsychosocial approach. Psychiatry, 57, 316-325.
99. Pau, K. Y., Kaynard, A. H., Hess, D. L. and Spies, H. G. (1991). Effects of neuropeptide Y on the in vitro release of gonadotropin-releasing hormone, luteinizing hormone, and beta-endorphin and pituitary responsiveness to gonadotropin-releasing hormone in female macaques. Neuroendocrinology, 53, 396-403.
100. Pennline, K. J., Roque-Gaffney, E. and Monahan, M. (1994). Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clinical Immunology Immunopathology, 71, 169-171.
101. Pijl, H., Koppeschaar, H. P. F., Cohen, A. F., Iestra, J. A., Schoemaker, H. C., Frölich, M., Onkenhout, W. and Meinders, A. E. (1993b). Evidence for brain serotonin-mediated control of carbohydrate consumption in normal weight and obese humans. International Journal of Obesity, 17, 513-520.
102. Pijl, H., Koppeschaar, H. P. F., Willekens, F. L. A., Frölich, M. and Meinders, A. E. (1993a). The influence of serotonergic neurotransmission on pituitary hormone release in obese and non-obese females. Acta Endocrinologica, 128, 319-324.
103. Polatin, P. B., Kinney, R. K., Gatchel, R. J., Lillo, E. and Mayer, T. G. (1993). Psychiatric illness and chronic back pain: the mind and the spine - which goes first? Spine, 18, 66-71.
104. Pomerleau, O. F. (1992). Nicotine and the central nervous system: biobehavioral effects of cigarette smoking. American Journal of Medicine, 93, 25-75.
105. Raine, A., Buchsbaum, M. S., Stanley, J., Lottenberg, S., Abel, L. and Stoddard, J. (1994). Selective reductions in prefrontal glucose metabolism in murderers. Biological Psychiatry, 36, 365-373.
106. Raiteri, M., Paudice, P. and Vallebuona, F. (1993). Release of cholecystokinin in the central nervous system. Neurochemistry International, 22, 519-527.
107. Reddy, B. V., Boyadjieva, N. and Sarkar, D. K. (1995). Effect of ethanol, propanol, butanol, and catalase enzyme blockers on β-endorphin secretion from primary cultures of hypothalamic neurons: evidence for a mediatory role of acetaldehyde in ethanol stimulation of β-endorphin release. Alcohol: Clinical and Experimental Research, 19, 339-342.
108. Rosenstein, E. D., Kunicka, J., Kramer, N. and Goldstein, G. (1994). Modification of cytokine production by piroxicam. Journal of Rheumatology, 21, 901-904.
109. Russ, M. J., Roth, S. D., Kakuma, T., Harrison, K. and Hull, J. W. (1994). Pain perception in self-injurious borderline patients: naloxone effects. Biological Psychiatry, 35, 207-209.
110. Russ, M. J., Roth, S. D., Lerman, A., Kakuma, T., Harrison, K., Shindledecker, R. D., Hull, J. and Mattis, S. (1992). Pain perception in self-injurious patients with borderline personality disorder. Biological Psychiatry, 32, 501-511.
111. Sahu, A., Dube, M. G., Phelps, C. P., Sninsky, C. A., Kalra, P. S. and Kalra, S. P. (1995). Insulin and insulin-like growth factor II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: a putative hypothalamic site for energy homeostasis. Endocrinology, 136, 5718-5724.
112. Saito, K., Markey, S. P. and Heyes, M. P. (1991). Chronic effects of gamma-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57BL6 mice. Brain Research, 546, 151-154.
113. Saland, L. C., Carr, J. A., Samora, A. and Tejeda, D. (1992). Benzodiazepine suppression of corticotropin-releasing factor (CRF)-induced beta-endorphin release from rat neurointermediate pituitary. Peptides, 13, 913-917.
114. Salter, M. (1992). Low serum cholesterol and suicide (letter). Lancet, 339, 1169.
115. Sandman, C. A., Barron, J. L., Chicz-DeMet, A. and DeMet, E. M. (1990). Plasma β-endorphin levels in patients with self-injurious behaviour and stereotypy. American Journal of Mental Retardation, 95, 84-92.
116. Sapolsky, R. M. (1993). Potential behavioural modification of glucocorticoid damage to the hippocampus. Behavior and Brain Research, 57, 175-182.
117. Schlesinger, L. B. (1980). Distinctions between psychopathic, sociopathic and anti-social personality disorders. Psychology Reports, 47, 15-21.
118. Shintani, F., Kanba, S., Nakaki, T., Nibuya, M., Kinoshita, N., Suzuki, E., Yagi, G., Kato, R. and Asai, M. (1993). Interleukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. Journal of Neuroscience, 13, 3574-3581.
119. Sjöholm, A. (1991). Cytokines inhibit proliferation and insulin secretion by clonal rat insulinoma cells (RINm5F) non-synergistically and in a pertussis toxin-insensitive manner. Immunology Letters, 30, 81-86.
120. Soloff, P. H., Cornelius, J. and George, A. (1991). The depressed borderline: one disorder or two? Psychopharmacology Bulletin, 27, 23-30.
121. Spanagel, R., Herz, A. and Shippenberg, T. S. (1991). Modulation of the mesolimbic dopaminergic system by beta-endorphin-(1-27) as assessed by microdialysis. European Journal of Pharmacology, 200, 319-324.
122. Spangelo, B. L. and Gorospe, W. C. (1995). Role of cytokines in the neuroendocrine-immune system axis. Frontiers in Neuroendocrinology, 16, 1-22.
123. Storm-Mathisen and A. Vaglum, P. (1994). Conduct disorder patients 20 years later: a personal follow-up study. Acta Psychiatrica Scandinavica, 89, 416-420.
124. Suarez-Pinzon, W. L., Strynadka, K., Schulz, R. and Rabinovitch, A. (1994). Mechanisms of cytokine-induced destruction of rat insulinoma cells: the role of nitric oxide. Endocrinology, 134, 1006-1010.
125. Taylor, M. W. and Feng, G. (1991). Relationship between interferon-γ, indolearaine-2,3-dioxygenase, and tryptophan catabolism. FASEB, 5, 2516-2522.
126. Taylor, D. V., Rush, D., Hetrick, W. P. and Sandman, C. A. (1993). Self-injurious behavior within the menstrual cycle of women with mental retardation. American Journal of Mental Retardation, 97, 659-664.
127. Terzic, M., Stimec, B., Solovic, V., Plecas, D. and Vojdovic, L. J. (1994). Is there a link between beta-endorphin and diabetes in pregnancy? Clinical and Experimental Obstetrics and Gynecology, 21, 91-93.
128. Träskman-Bendz, L., Ekman, R., Regnéll, G. and Öhman, R. (1992). HPA-related CSF neuropeptides in suicide attempters. European Neuropsychopharmacology, 2, 99-106.
129. Tsigos, C., Givson, S., Crosby, S. R., White, A. and Young, R. J. (1995). Cerebrospinal fluid levels of beta endorphin in painful and painless diabetic polyneuropathy. Journal of Diabetes Complications, 9, 92-96.
130. Twist, D. J., Culpepper-Morgan, J. A., Ragnarsson, K. T., Petrillo, C. R. and Kreek, M. J. (1992). Neuroendocrine changes during functional electrical stimulation. American Journal of Physical Medicine and Rehabilitation, 71, 156-163.
131. Vahabzadeh, A., Boutelle, M. G. and Fillenz, M. (1995). Effects of changes in rat brain glucose on serotonergic and noradrenergic neurons. European Journal of Neuroscience, 7, 175-179.
132. Van den Bergh, P., Rozing, J. and Nagelkerken, L. (1994). Identification of distinct sites of beta-endorphin that stimulate lymphokine production by murine CD4+ T cells. Lymphokine and Cytokine Research, 13, 63-69.
133. Vescovi, P. P., Coiro, V., Volpi, R., Giannini, A. and Passeri, M. (1992). Plasma beta-endorphin, but not met-enkephalin levels are abnormal in chronic alcoholics. Alcohol and Alcoholism, 27, 471-475.
134. Virgin, Jr., C. E., Ha, TP.-T., Packan, D. R., Tombaugh, G. C., Yang, S. H., Horner, H. C. and Sapolsky, R. M. (1991). Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes: implications for glucocorticoid neurotoxicity. Journal of Neurochemistry, 57, 1422-1428.
135. Vikkunen, M. (1979). Serum cholesterol in antisocial personality. Neuropsychobiology, 5, 27-30.
136. Virkkunen, M. and Linnoila, M. (1993). Brain serotonin, Type II alcoholism and impulsive violence. Journal of Studies on Alcohol, 511, 163-169.
137. Virkkunen, M., Rawlings, R., Tokola, R., Poland, R. E., Guidotti, A., Nemeroff, C., Bissette, G., Kalogeras, K., Karonen, S. L. and Linnoila, M. (1994). CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers. Archives of General Psychiatry, 51, 20-27.
138. Wang, Z. P., Man, S. Y. and Tang, F. (1993). Age-related changes in the contents of neuropeptides in the rat brain and pituitary. Neurobiology and Aging, 14, 529-534.
139. Watzl, B., Scuderi, P. and Watson, R. R. (1991). Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitro. International Journal of Immunopharmacology, 13, 1091-1097.
140. Wells, R. A. (1988). A fresh look at the muddy waters of psychopathy. Psychology Reports, 63, 843-856.
141. Wettstein, J. G., Earley, B. and Junien, J. L. (1995). Central nervous system pharmacology of neuropeptide Y. Pharmacology and Therapeutics, 65, 397-414.
142. Widiger, T. A. and Weissman, M. M. (1991). Epidemiology of borderline personality disorder. Hospital and Community Psychiatry, 42, 1015-1021.
143. Wong, M. T., Lumsden, J., Fenton, G. W. and Fenwick, P. B. (1994). Electroencephalography, computed tomography and violence ratings of male patients in a maximum-security mental hospital. Acta Psychiatrica Scandinavica, 90, 97-101.
144. Yochelson, S. and Samenow, S. E. (1976). The Criminal Personality, Vol. I. A Profile For Change. Jason Aronson I.c, New Jersey.
145. Young, W. S. (1986). Periventricular hypothalamic cells in the rat brain contain mRNA. Neuropeptides, 8, 93-97.
146. Young, E. A., Day, R., Schafer, M., Watson, S. J. and Akil, H. (1993). Altered ratios of beta-endorphin: beta-lipotropin released from anterior lobe corticotropes with increased secretory drive, II. Repeated stress. Journal of Neuroendocrinology, 5, 121-126.
147. Zimmerman, M., Coryell, W., Pfohl, B., Coryell, W., Stangi, D. and Corenthal, C. (1988). Diagnosing personality disorder in depressed patients. Archives of General Psychiatry, 45, 733-737.